Medicine guide
Regranex
·
- Prescription status not stated
- Skin
- Active substance
- Becaplermin
- Used in
- Skin
- Made by
- Janssen-Cilag International NV
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Regranex is indicated, in association with other good wound care measures, to promote granulation and thereby the healing of full-thickness, neuropathic, chronic, diabetic ulcers less than or equal to 5 cm2.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Janssen-Cilag International NV |
|---|---|
| Active substance | Becaplermin |
| Used in | Skin |
| Classification | D03AX06 · Skin |
| Authorised on | 1999-03-29 |
| Last updated by the regulator | 2012-08-15 |
| EMA product number | EMEA/H/C/000212 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).